
Axis Biotech Private Limited
About Axis Biotech Private Limited
Data last updated:
Axis Biotech Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 28 November 1942 and has been in existence for over 84 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85110WB1942PTC011115.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Calcutta Nursing Home Pvt Ltd. It is led by directors Gourav Bajaj and Sajan Kumar Bajaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 145 Rashbehari Avenue, Kolkata, West Bengal, India – 700029.
As per the financials filed for FY 2024, the company reported a revenue of ₹17,200, a decline of 93% compared to the previous year. For the same year it recorded a net profit of ₹3,078 (net margin 17.9%) and EBITDA of ₹4,118 (EBITDA margin 23.9%).
Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Axis Biotech Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address145 Rashbehari Avenue, Kolkata, West Bengal, India – 700029
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Axis Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Axis Biotech Private Limited
FY 2025 filings availableAxis Biotech Private Limited reported revenue of ₹17,200 (down 93% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 93% in the latest year. EBITDA fell 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,118 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,078 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.9% | ||||
| Net Profit Margin | 17.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axis Biotech Private Limited, buy the company report.
Board of directors of Axis Biotech Private Limited
Axis Biotech has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gourav Bajaj Also directs: MRP Commercial Pvt. Ltd., Kishanganj Jute Mills Limited, Axis Mining Private Limited and 5 more | Additional Director | 12 Sep 2024 | 2 Years 1 Months | Current |
| Sajan Kumar Bajaj Also directs: MRP Commercial Pvt. Ltd., Kishanganj Jute Mills Limited, Axis Mining Private Limited and 5 more | Additional Director | 30 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Axis Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auroveda Integral Foundation | ₹18,000 (FY 2025) | -84.0% | Jaipur, Rajasthan, India | |||
| Omega Century Institute of Oncology Private Limited | ₹18,000 (FY 2025) | -99.0% | Hyderabad, Telangana, India | |||
| Medpals Healthcare Private Limited | ₹17,850 (FY 2021) | -98.0% | Doddaballapur, Karnataka, India | |||
| Girik Estates Pvt.Ltd. | ₹17,583 (FY 2025) | Kolkata, West Bengal, India | ||||
| Healwheel Healthcare Services Private Limited | ₹17,450 (FY 2025) | 1.0% | Kolkata, West Bengal, India | |||
| Axis Biotech Private Limitedthis company | ₹17,200 (FY 2024) | ₹3,078 | 17.9% | -93.0% | Kolkata, West Bengal, India | |
| Jamul Healthcare Private Limited | ₹17,000 (FY 2024) | -69.0% | Mphb Chhawni, Chhattisgarh, India | |||
| Infinity Learning Private Limited | ₹16,988 (FY 2024) | -92.0% | Bangalore, Karnataka, India | |||
| Neurostellar Private Limited | ₹16,960 (FY 2025) | -99.0% | Chennai, Tamil Nadu, India | |||
| Akinna Health Care Private Limited | ₹16,723 (FY 2024) | New Delhi, Delhi, India | ||||
| Rays Medicare Private Limited | ₹16,193 (FY 2019) | -88.0% | Delhi, India |
To see the full peer comparison of Axis Biotech Private Limited, buy the company report.
Auditor
Axis Biotech Private Limited is audited by S ROY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S ROY & ASSOCIATES | FY 2023 | 310039E |
Shareholding
The shareholding of Axis Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Axis Biotech Private Limited, buy the company report.
Legal cases
Axis Biotech Private Limited has 2 court cases on record: 2 filed by Axis Biotech. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against C.E.S.C. Ltd. | Disposed |
| Calcutta High Court | Court case (CRR) | Filed by the company against an individual | Disposed |
To see the full case history of Axis Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axis Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Axis Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Axis Biotech Private Limited has 12 board changes on record since 2007: 2 appointments and 10 cessations. The latest: Gourav Bajaj was appointed as Additional Director on 12 Sep 2024.
3 earlier events are in the company report.
Frequently asked questions
Axis Biotech is an active private limited company based in Kolkata, West Bengal, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 28 November 1942 (84+ years old) and is registered under CIN U85110WB1942PTC011115.
Axis Biotech has 2 current directors:
- Gourav Bajaj - Additional Director
- Sajan Kumar Bajaj - Additional Director
The latest financial statements of Axis Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Axis Biotech is U85110WB1942PTC011115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axis Biotech has 2 court cases on record: 2 filed by the company.
Axis Biotech was incorporated on 28 November 1942, making it 84+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Axis Biotech by revenue are Auroveda Integral Foundation, Omega Century Institute of Oncology Private Limited, Medpals Healthcare Private Limited, Girik Estates Pvt.Ltd, Healwheel Healthcare Services Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Gourav Bajaj was appointed as Additional Director on 12 Sep 2024. Sajan Kumar Bajaj was appointed as Additional Director on 30 Oct 2021. Shanta Sarda ceased to be Director on 30 Oct 2021. Axis Biotech has 12 board changes on record in total.
The registered office of Axis Biotech is at 145 Rashbehari Avenue, Kolkata, West Bengal, India – 700029.
Axis Biotech operates in the healthcare industry, in the preventive health services segment.
The compliance status of Axis Biotech is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.

